Compounds > erlotinib hydrochloride
Page last updated: 2024-09-05

erlotinib hydrochloride and Disseminated Intravascular Coagulation

erlotinib hydrochloride has been researched along with Disseminated Intravascular Coagulation in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Cho, JH; Jeon, SH; Kim, HJ; Kim, JS; Kwak, SM; Lee, HL; Nam, HS; Ryu, JS1
Pavlidis, N; Pentheroudakis, G; Vassou, A; Voulgaris, E1

Other Studies

2 other study(ies) available for erlotinib hydrochloride and Disseminated Intravascular Coagulation

ArticleYear
Dramatic response of acute disseminated intravascular coagulation to erlotinib in a patient with lung adenocarcinoma with activating EGFR mutation.
    The Journal of international medical research, 2018, Volume: 46, Issue:1

    Topics: Adenocarcinoma; Adenocarcinoma of Lung; Aged, 80 and over; Antineoplastic Agents; Carcinoma, Basal Cell; Disseminated Intravascular Coagulation; ErbB Receptors; Erlotinib Hydrochloride; Gene Expression; Humans; Lung Neoplasms; Male; Mutation; Protein Kinase Inhibitors; Treatment Outcome

2018
Disseminated intravascular coagulation (DIC) and non-small cell lung cancer (NSCLC): report of a case and review of the literature.
    Lung cancer (Amsterdam, Netherlands), 2009, Volume: 64, Issue:2

    Topics: Aged; Antineoplastic Agents; Carcinoma, Non-Small-Cell Lung; Cisplatin; Disseminated Intravascular Coagulation; Erlotinib Hydrochloride; Fatal Outcome; Female; Humans; Lung Neoplasms; Protein Kinase Inhibitors; Quinazolines; Thrombocytopenia

2009